Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JM Loveridge is a long-established UK-based pharmaceutical company specializing in the manufacture and distribution of chemicals, galenicals, and medical sundries. Founded in the early 20th century, the company became a prominent supplier to community and hospital pharmacies, providing a wide range of raw materials, ointments, and liquids. The firm played a critical role in the UK pharmaceutical supply chain by offering specials and unlicensed medicinal products tailored to specific patient needs. In 2006, the company was acquired by Mawdsleys, a leading independent pharmaceutical wholesaler in the United Kingdom. Following the acquisition, JM Loveridge's operations were integrated into the Mawdsleys group, though the name remains recognized in the industry for its heritage in chemical supply.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on JM Loveridge.